Vaxcyte, Inc.PCVXNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank63
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P63
Within normal range
vs 5Y Ago
-40.9x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025-44.84%
2024-52.51%
2023-73.97%
2022-40.53%
2021-160.34%
20201.10%
2019-54.75%
2018-203508.90%
20170.00%